0.0170
0.0000
(0.00%)
As of April 3 at 4:00:00 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2023) | Next Qtr. (Jan 1970) | Current Year (2023) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -0.18 | -- | -0.2 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2023) | Next Qtr. (Jan 1970) | Current Year (2023) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in USD | 6/30/2022 | 9/30/2022 | 12/31/2022 | 3/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.01 | 0.01 | 0.16 | -0.03 |
| EPS Actual | -0.18 | -0.01 | 0.01 | -0.07 |
| Difference | -0.19 | -0.02 | -0.15 | -0.04 |
| Surprise % | -1,900.00% | -200.00% | -96.35% | -133.33% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2023) | Next Qtr. (Jan 1970) | Current Year (2023) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2023) | Next Qtr. (Jan 1970) | Current Year (2023) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 1 | -- | 1 | -- |
| Down Last 30 Days | 1 | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| EMMA | -- | -- | -- | -- |
| S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Related Tickers
NVAX.MX Novavax, Inc.
116.50
+5.91%
SNPX Synaptogenix, Inc.
2.1500
-5.70%
KLRS Kalaris Therapeutics, Inc.
7.51
+1.42%
LSB LakeShore Biopharma Co., Ltd
2.1100
-6.22%
FENC Fennec Pharmaceuticals Inc.
5.31
-5.10%
GNFT Genfit S.A.
3.3401
-5.91%
ELDN Eledon Pharmaceuticals, Inc.
2.9150
-7.75%
MAZE Maze Therapeutics, Inc.
8.94
-4.08%
DMAC DiaMedica Therapeutics Inc.
3.4900
-5.16%
FULC Fulcrum Therapeutics, Inc.
2.5050
-1.76%